Sera Prognostics, Inc.
General ticker "SERA" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $129.9M (TTM average)
Sera Prognostics, Inc. does not follow the US Stock Market performance with the rate: -19.4%.
Estimated limits based on current volatility of 1.2%: low 2.03$, high 2.08$
Factors to consider:
- Total employees count: 72 (+12.5%) as of 2025
- Top business risk factors: Net losses, Capital shortage, Dependence on key products, Customer concentration, Market competition
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.24$, 5.61$]
- 2026-12-31 to 2027-12-31 estimated range: [1.93$, 4.99$]
Financial Metrics affecting the SERA estimates:
- Positive: with PPE of -4.9 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: 69.38 < Shareholder equity ratio, % of 73.98 <= 81.92
- Positive: -16.84 < Industry operating profit margin (median), % of -16.21
- Positive: -28.70 < Return on assets ratio (scaled to [-100,100]) of -23.85
- Positive: Inventory ratio change, % of 0.02 <= 0.41
- Positive: -6.44 < Industry operating cash flow per share per price (median), % of -5.72
- Positive: -18.95 < Investing cash flow per share per price, % of -17.87
Short-term SERA quotes
Long-term SERA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.31MM | $0.08MM | $0.08MM |
| Operating Expenses | $40.13MM | $36.71MM | $36.59MM |
| Operating Income | $-39.82MM | $-36.63MM | $-36.50MM |
| Non-Operating Income | $3.58MM | $3.74MM | $4.58MM |
| Interest Expense | $0.06MM | $0.03MM | $0.01MM |
| R&D Expense | $15.22MM | $14.73MM | $13.17MM |
| Income(Loss) | $-36.24MM | $-32.90MM | $-31.93MM |
| Net Income(Loss)* | $-36.24MM | $-32.90MM | $-31.93MM |
| Stockholders Equity | $70.16MM | $47.80MM | $75.41MM |
| Assets | $95.44MM | $72.58MM | $101.93MM |
| Operating Cash Flow | $-27.19MM | $-14.19MM | $-25.62MM |
| Capital expenditure | $0.13MM | $1.10MM | $0.73MM |
| Investing Cash Flow | $0.44MM | $11.74MM | $-28.50MM |
| Financing Cash Flow | $0.75MM | $2.61MM | $54.03MM |
| Earnings Per Share** | $-1.16 | $-0.99 | $-0.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.